Cipla adapts its diversified model to navigate tariff challenges, despite a 39% drop in Q1 net profit.

Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a high base, while revenue from…

Cipla adapts its diversified model to navigate tariff challenges, despite a 39% drop in Q1 net profit.